A comparison was made of the three 22-gauge ported intravenous cannulae available in New Zealand-Venflon 2, ® Vasofix Braunule® and Insyte. ® All cannulae performed satisfactorily in terms of overall success of cannulation although significant differences were apparent in both clinical and laboratory performance. Anaesthetists' clinical preference was for Insyte and Venflon 2 brands, perceiving these to have greater ease of handling and better packaging. In a series of laboratory studies, Vasofix was found to have the highest flowrate, the fastest time to flashback and the lowest valve opening pressure. Insyte required the least force of penetration. Venjlon 2 had the greatest margin of safety between pressure to inject through the port and pressure required to blow the syringe/port assembly apart. Potential problems were identified with the Insyte port valve mechanism.
In recent years the transfer of viral infections by needle-stick injury has become an important factor in determining anaesthetists' intravenous practice. 14 Although ported cannulae have been available for over a decade there is renewed interest in the use of these devices as a method of reducing needle use. The presentation of anaesthetic agents in vials and ampoules with luer-compatible connections, for example "Polyamp Luer Fit"@, is now in increasing use and further obviates the use of needles for the drawing up of drugs. The combined use of cannulae with injection ports and drug presentations which obviate needles for drawing up are potentially useful in reducing the risk of needle-stick injury to anaesthetists.
In our own hospital the majority of patients are anaesthetised through fine gauge (22 SWG) non-ported cannulae which are removed immediately following anaesthesia. Usually a luer plug with a rubber bung is fitted to these cannulae through which the induction agents are injected using a needle. The use of these fine-gauge cannulae avoids the necessity of inserting larger sized cannulae in awake patients using local anaesthesia. Where necessary, large-bore cannulae are inserted following induction of anaesthesia and are used for fluid administration and are generally for long-term intravenous placement. Unfortunately, ported cannulae have the potential for increasing the risk of infection due to colonisation of the cannula port 5.6 and in some countries, such as United States of America and Canada, are not used for this reason.
As a method of reducing needle use we wished to replace the fine-gauge cannula used for induction and drug administration by a ported device. We did not consider it desirable to replace the larger-bore cannula because of the potential for infection and because all drugs can be administered intraoperatively via the smaller-ported cannula.
In this study we evaluated several aspects of the performance of the three brands of 22-gauge ported cannulae which are currently available in New Zealand.
METHOD
The study was conducted on the Venflon 2 (Viggo-Spectramed), Vasofix Braunule (B. Braun Melsungen AG) and Insyte (Becton Dickinson) brands of 22-gauge ported cannulae ( Figure 1 ). The cannulae were assessed for clinical performance and catheter distortion following removal from patients. Certain other characteristics were assessed under laboratory conditions. The external diameter of the cannula and its introducing needle were measured 15 mm from the catheter tip with a micrometer (the external diameter was measured with the needle in situ). 8 Cannula wall thickness was calculated as one half the difference between external catheter diameter and needle diameter.
Flowrate was determined according to British Standards Protocol BS4843. 8 A constant level tank of de-ionised water (at room temperature) with a delivery tube capable of flow rates greater than 500 mllminute with a height of 100 cm from the water level to the cannula being tested was used.
For the assessment of flashback, a pressure chamber with a plastic diaphragm at one end was filled with red dye and pressurised to 10 cm of water. Each cannula was then connected to the diaphragm and the time taken for the appearance of dye was recorded using a stopwatch.
For the measurement of dead space volume, each cannula was weighed (without needle) using a Mettler H35 balance accurate to O.OOOlg. The cannula was then filled with de-ionised water via the injection port (carefully to avoid bubbles of air) and weighed again. The deadspace was calculated as the difference between measurements, assuming that 1.0 ml of de-ionised water weighs 1.0 gram.
Pressure studies
(a) Pressure required to inject through the port of the cannula. An infusion pump (Sage Instruments Model 351) set at a rate of 12 mllhour of de-ionised water, and a pressure transducer via aY-connection, was attached to the injection port of the cannula. The pressure required for the flow of water to occur was measured.
(b) The pressure required to separate the syringe/ injection port unit was recorded in the following way. With the cannula tip occluded, a constant infusion via a 10 mlluer slip syringe (Terumo) was attached to the injection port of the cannula connected to a pressure monitor capable of measuring up to 75 psi (3750 mmHg). The injection port of the cannula to be tested was connected to the syringe with a horizontal force of 1.5 kg for 5 seconds. The pressure at which the syringe/port connection blew apart was measured.
The penetration force required to pierce a paper diaphragm of 0.1 mm thickness was measured by connecting the cannula to a force transducer and allowing it to pierce the paper diaphragm at a rate of 1.6 mm/sec. Only one measurement was made for each cannula. At each trial, two measurements were taken: Anac5ti1esia and Inrel7';irc Care, ~ol. 21, .\'u. 3, June, 1993 the maximum force required for penetration of the needle, and the maximum force required for the following catheter.
For measurement of cannula flexibility, the lateral force required to displace the needle tip to a distance of 2, 4 and 6 mm was measured.
For the clinical study, categorical data was analysed using the Chi-squared test and ordinal data using Kruskal Wallis for ranking of non-parametric data. P < 0.05 was considered to indicate a significant result.
RESULTS
1. Clinical Performance. Of the 1500 cannulae, 1278 completed forms were returned. Questions relating to ease of penetration, ease of handling, ease of securing stopcock, ease of removal from packaging, preference for routine use, and overall scaling were found to be significantly better with the Insyte and Venflon 2 cannulae in comparison to Vasofix ( Table 2 ). No significant difference was found for success of cannulation, kinking, blood spillage and skin fixation. Blood spillage occurred in 10070 of all cannulations. In 96% of cases the anaesthetists believed there had been a reduction in needle use by using these ported cannulae. 3. Laboratory Studies. Table 3 gives the external diameters, needle diameter, wall thickness, flowrate, flashback, deadspace volume, pressure required to inject through the port of the cannula, pressure needed to blow apart the syringe/port connection, penetration force and cannula flexibility. There were small differences in catheter dimensions, which were translated into larger differences in catheter flowrate. Vasofix had the largest internal diameter and was associated with a flowrate 50% greater than the smallest internal diameter catheter, Venflon 2. This difference was also seen in time to flashback where Venflon 2 was slower in comparison to both Insyte and Vasofix. The Vasofix and Venflon 2 cannulae had the smallest deadspace and Insyte had the greatest. The pressures required for opening of the injection port were greater for Insyte in comparison with either Vasofix or Venflon 2. However, the ability of the ported mechanism of the Insyte cannula to withstand presmrisation was less than that for the other cannulae. The penetration forces required for the needles of each brand were comparable, although the Insyte cannula required the lowest force for penetration. The Insyte cannula/needle was more flexible than Venflon 2 or Vasofix. 
DISCUSSION
The use of plastic intravenous cannulae has become an integral part of routine anaesthetic practice. Until the present it was routine in our own hospital to use rubber-bunged, non-ported intravenous cannulae through which anaesthetic drugs could be administered by needle injection. With recent problems and concerns associated with needle-stick injuries we have examined three brands of ported intravenous cannulae with a view to reducing needle usage. A high proportion of responses from this study indicated that the use of these cannulae had resulted in a reduction in needle usage, although it is of note that at 10070 of cannulations skin contact with blood occurred.
The anaesthetists' subjective impression was that the Insyte and Venflon 2 cannulae were easier to remove from the packaging, easier to handle and easier to attach the stopcock. These two cannulae have the stopcock attached to the end of the cannula scabbard whereas the Vasofix stopcock is packaged separately within a sterile package in the cannula packaging. Although this allows the stopcock to be retained with sterility if not immediately used, its attachment was considered more awkward.
Flowrate is influenced by many factors, the most important of which is the internal diameter of the cannula (linearly related to tip diameter). 9 In this study, the Vasofix brand had the largest internal diameter and a significantly higher flowrate. Although flow may be of lesser relevance for the 22-gauge cannulae in comparison with the larger sizes, some anaesthetists do administer fluids to children and adults through smallgauge cannulae and hence relative flow may be important. Flowrate may also be relevant with regard to the time to flashback, an important consideration as a guide to placement when inserting fine-gauge needles. Factors influencing flashback include cannula size and flashback chamber visibility, as well as vein size and venous occlusion pressure. In the laboratory flashback test, consistent with the trends in flow rate, Vasofix had the fastest and Venflon 2 the slowest time to flashback.
Low deadspace is important in the event that small quantities of potent, potentially dangerous drugs (e.g. suxamethonium) are left in the cannula at the end of the case. Ill,ll The danger of the cannula being flushed in the recovery room or in the ward can be significant. Although the deadspace volumes of the three cannulae were small, equivalent doses of suxamethonium which might remain range from 7 mg for Vasofix and Venflon 2 to 12.5 mg for Insyte.
During the clinical part of the trial, informal comments were made by a number of anaesthetists of the different pressures required to overcome the resistance of the valve mechanism of the ported cannulae as well as the occasional separation of syringe from the port during drug injection. The pressure studies were designed to examine the pressure required to overcome the resistance of the injection ports during slow infusion as well as the pressure required to separate the port from an attached syringe. Of the three brands, Insyte required the highest pressure to overcome the resistance of its valve mechanism. The Insyte also required the least pressure to separate the syringe from the port and, unlike the Venflon 2 and Vasofix cannulae, which allow the use of luer locking syringes, the lnsyte cannula can only be used with luer slip syringes. Thus the margin of safety was the least for this brand. Venflon 2 had the highest margin of safety. We believe this margin may have clinical importance because syringe/cannula separation during anaesthetic induction may cause unknown quantities of drug to be lost. The observation of higher injection pressure for the Insyte system can be explained by the differing valve mechanism of the cannulae. The Insyte has a smaller orifice at 90 degrees to the direction of injection, while the other cannulae have larger openings with valves that are displaced in the direction of injection. The reason for Insyte having lower separation pressure may relate to the material and design of the injection port. Both Venflon 2 and Vasofix have a port housing which is an integral structure made from the one material (polypropylene) but in Insyte the port is constructed in two separate units of differing materials (polypropylene and polyethylene).
The clinical questionnaire indicated that anaesthetists perceive the Venflon 2 and Insyte cannulae to have the greatest ease of penetration. In the laboratory study, only Insyte was found to be different in this respect, and this difference was for the catheter rather than the needle. Thus all needles penetrated with a similar force, but, as the catheter penetrated, greater force was required for Vasofix and Venflon. This is explained by the profile of the catheters on the needle where the Insyte smoothly tapers down to the needle surface, while the others have been cut to a blunt edge. Although Vasofix was considered to have poor penetration in the clinical study, it was observed in the laboratory to be no different to the Venflon 2. It is possible that this discrepancy might be explained by the Venflon 2 cannula being observed to be the least flexible of the three. Needle stiffness may be useful in giving the anaesthetist greater control over needle insertion and hence reducing the necessity for having a perfectly smooth catheter profile.
In summary, the Venflon 2 and Insyte systems were preferable to Vasofix in the clinical part of this study. On laboratory testing, however, there were a number of areas where the Insyte system was less favourable. We would recommend to the manufacturers that the Insyte valve mechanism could be improved, both in regard to syringe/port fit and valve opening pressure. Had the clinical study favoured the Vasofix system, the added advantage of fast flashback and high flow rate would have made this a satisfactory cannula for routine use. It is possible that the anaesthetists' clinical impression of the Vasofix system could have been significantly improved if the stopcock was affixed directly to the needle cover rather than being packaged separately.
